A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned

Status Completed

Clinical Trial Summary

The purposes of this study are to determine 1) the safety of pemetrexed and any side effects that might be associated with it 2) whether pemetrexed can help patients with small cell lung cancer live longer 3) whether pemetrexed can make tumors smaller or disappear and for how long and 4) to see if patients feel better while taking pemetrexed

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00191750
Study type	Interventional
Source	Eli Lilly and Company
Contact
Status	Completed
Phase	Phase 2
Start date	July 2004
Completion date	September 2006

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01860898` - A Phase I Study of iPS Cell Generation From Patients With COPD	N/A
Completed	`NCT00046787` - Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer	Phase 2
Recruiting	`NCT03212404` - Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers	Phase 1
Recruiting	`NCT03554473` - M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers	Phase 1/Phase 2
Terminated	`NCT00094978` - Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum	Phase 1
Recruiting	`NCT04162041` - Topotecan Plus M6620 (VX-970) vs. Topotecan Alone in People With Relapsed Small-Cell Lung Cancer	Phase 2
Completed	`NCT03092739` - A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens
Completed	`NCT00305942` - Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer	Phase 2
Terminated	`NCT00324558` - Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)	Phase 2
Completed	`NCT00359359` - A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer	Phase 1/Phase 2
Recruiting	`NCT05461430` - Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
Recruiting	`NCT02366741` - Neurocognitive Function After Prophylactic Cranial Irradiation & Hippocampal Sparing in LD SCLC Patients - a Pilot Study	N/A
Active, not recruiting	`NCT01900951` - Temozolomide as Maintenance Therapy in Small Cell Lung Cancer	Phase 2
Completed	`NCT00826644` - Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient	Phase 3
Completed	`NCT00284154` - Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer	Phase 2
Recruiting	`NCT00100256` - Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy	Phase 1/Phase 2
Completed	`NCT00126828` - Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer	Phase 1/Phase 2
Terminated	`NCT02034123` - Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma	Phase 1
Recruiting	`NCT05500391` - Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring	Phase 2
Recruiting	`NCT02688036` - Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC	Phase 3